Prognose

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizations Mr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financing Mr.» Mehr auf globenewswire.com
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced diagnostic-guided therapies, today announced that data from its pivotal clinical trial evaluating the inFoods® IBS test in treating IBS sufferers has been published in the June 2025 issue of Gastroenterology , the official journal of the American Gastroenterological Association and the highest-impact publication in the GI field.» Mehr auf globenewswire.com
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
IRVINE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), an innovator in diagnostic-guided therapy, today announced compelling real-world results demonstrating the effectiveness of its inFoods® IBS product, along with the launch of a proprietary real-time patient feedback system to enhance symptom tracking and improve patient outcomes.» Mehr auf globenewswire.com

Im letzten Quartal hatte BIOMERICA INC. einen Umsatz von 1,08 Mio€ und ein Nettoeinkommen von −1,12 Mio€